About: Firebrick Pharma Limited develops and commercializes povidone-iodine (PVP-I) products under the Nasodine brand in Asia, North America, Europe, and internationally. It offers nasal and throat spray PVP-I products for the treatment of common cold. The company was incorporated in 2012 and is based in Melbourne, Australia.
Sector: Healthcare
Industry: Drug Manufacturers - General
Latest price: A$0.03 (-3.45%)
FRE ASX Firebrick Pharma Ltd
Firebrick Pharma Ltd share price
FRE price activity
Último preço
$ 0,030
Variação (24h)
-0,00 AUD (-3,45%)
Volume
60K
Volume (média 4 sem.)
-
Abertura
$ 0,03
Variação do dia
$ 0,03 - $ 0,03
Fechamento anterior
$ 0,03
Último negócio
01 Oct, 3:26 am GMT+0
Atrasado
01 Oct, 3:26 am GMT+0
FRE price performance
Atrasado
01 Oct, 3:26 am GMT+0
quote.marketSignals